BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,147 | -24.6% | 17,345 | +0.1% | 0.00% | – |
| Q2 2023 | $553,218 | +6.9% | 17,326 | +2.5% | 0.00% | – |
| Q1 2023 | $517,631 | -26.5% | 16,905 | -6.1% | 0.00% | -100.0% |
| Q4 2022 | $704,215 | -13.7% | 18,006 | +5.2% | 0.00% | 0.0% |
| Q3 2022 | $816,000 | +19.8% | 17,111 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $681,000 | -44.4% | 17,573 | -17.8% | 0.00% | 0.0% |
| Q1 2022 | $1,225,000 | -26.9% | 21,368 | +1.7% | 0.00% | 0.0% |
| Q4 2021 | $1,675,000 | -27.8% | 21,017 | -21.1% | 0.00% | -50.0% |
| Q3 2021 | $2,319,000 | -13.8% | 26,649 | +27.6% | 0.00% | 0.0% |
| Q2 2021 | $2,689,000 | +66.2% | 20,892 | +3.3% | 0.00% | +100.0% |
| Q1 2021 | $1,618,000 | -4.7% | 20,218 | -2.7% | 0.00% | 0.0% |
| Q4 2020 | $1,697,000 | – | 20,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |